Based on 6 analysts giving stock ratings to Caribou Biosciences Inc in the past month.
In the current month, CRBU has received 2 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. CRBU average Analyst price target in the last month is 5.600.
Based on analysts' estimates, CRBU EPS is projected to reach -0.100 in FY2026Q4, following reported EPS of -0.247 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.25, while Caribou Biosciences IncCRBU's earnings per share (EPS) for the previous quarter was USD -0.24. EPS for the next quarter is expected at USD -0.10.